106 related articles for article (PubMed ID: 18758641)
1. Bcl-2 expression in Hodgkin's lymphoma progression.
Flangea C; Potencz E; Mihăescu R; Gîju S; Anghel A
Rom J Morphol Embryol; 2008; 49(3):357-63. PubMed ID: 18758641
[TBL] [Abstract][Full Text] [Related]
2. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
[TBL] [Abstract][Full Text] [Related]
3. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
Macák J; Bertová M
Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
[TBL] [Abstract][Full Text] [Related]
4. Expressions of latent membrane protein 1, p53 and bcl-2 proteins and their significance in Hodgkin's lymphoma.
Qi ZL; Zhao T; Zhou XH; Zhang JH; Han XQ; Zhu MG
Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):225-7. PubMed ID: 12651235
[TBL] [Abstract][Full Text] [Related]
5. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
[TBL] [Abstract][Full Text] [Related]
6. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
Chen XQ; Wang WL; Huang GS
Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
[TBL] [Abstract][Full Text] [Related]
7. [Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].
Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
Acta Med Croatica; 2004; 58(3):183-6. PubMed ID: 15503680
[TBL] [Abstract][Full Text] [Related]
8. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
Das DK; Francis IM; Sharma PN; Sathar SA; John B; George SS; Mallik MK; Sheikh ZA; Haji BE; Pathan SK; Madda JP; Mirza K; Ahmed MS; Junaid TA
Diagn Cytopathol; 2009 Aug; 37(8):564-73. PubMed ID: 19373880
[TBL] [Abstract][Full Text] [Related]
10. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
Basu D; Roy SK
Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
[TBL] [Abstract][Full Text] [Related]
11. [Hodgkin's disease in Zaire: histological and anatomo-clinical profile].
Mubikayi L; Kalengayi MM
IARC Sci Publ; 1984; (63):675-85. PubMed ID: 6536628
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
Lee MY; Tan TD; Feng AC
Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases.
Quiñones-Avila Mdel P; Gonzalez-Longoria AA; Admirand JH; Medeiros LJ
Am J Clin Pathol; 2005 May; 123(5):651-6. PubMed ID: 15981804
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical prognostic factors of primary refractory Hodgkin's lymphoma].
Filatova LV; Gershanovich ML; Plotnikova AA; Turkevich EA; Ivantsov AO; Klimashevskiĭ VF
Vopr Onkol; 2014; 60(5):625-9. PubMed ID: 25816669
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma.
Zyada MM; Grawish ME; Elsabaa HM
Ann Diagn Pathol; 2009 Oct; 13(5):313-21. PubMed ID: 19751908
[TBL] [Abstract][Full Text] [Related]
16. Dural infiltration of metastatic Hodgkin's lymphoma.
Elwell VA; Carney L; Johns P; Grieve JP
Br J Neurosurg; 2008 Jun; 22(3):439-40. PubMed ID: 18568736
[TBL] [Abstract][Full Text] [Related]
17. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
18. Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case.
Seliem RM; Chikwava K; Swerdlow SH; Young RH; Ferry JA
Int J Surg Pathol; 2007 Apr; 15(2):207-12. PubMed ID: 17478785
[TBL] [Abstract][Full Text] [Related]
19. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
[TBL] [Abstract][Full Text] [Related]
20. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]